184 related articles for article (PubMed ID: 22443586)
1. 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.
Liu J; Nguyen TT; Dupart PS; Sridhar J; Zhang X; Zhu N; Stevens CL; Foroozesh M
Chem Res Toxicol; 2012 May; 25(5):1047-57. PubMed ID: 22443586
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
[TBL] [Abstract][Full Text] [Related]
3. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
[TBL] [Abstract][Full Text] [Related]
4. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.
Liu J; Taylor SF; Dupart PS; Arnold CL; Sridhar J; Jiang Q; Wang Y; Skripnikova EV; Zhao M; Foroozesh M
J Med Chem; 2013 May; 56(10):4082-92. PubMed ID: 23600958
[TBL] [Abstract][Full Text] [Related]
5. Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.
Sridhar J; Ellis J; Dupart P; Liu J; Stevens CL; Foroozesh M
Drug Metab Lett; 2012; 6(4):275-84. PubMed ID: 23506553
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
7. Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme.
Sridhar J; Liu J; Komati R; Schroeder R; Jiang Q; Tram P; Riley K; Foroozesh M
Drug Metab Lett; 2017; 10(4):270-277. PubMed ID: 28000546
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.
Sridhar J; Liu J; Foroozesh M; Klein Stevens CL
Chem Res Toxicol; 2012 Feb; 25(2):357-65. PubMed ID: 22185593
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
10. Ethynylflavones, highly potent, and selective inhibitors of cytochrome P450 1A1.
Goyal N; Liu J; Lovings L; Dupart P; Taylor S; Bellow S; Mensah L; McClain E; Dotson B; Sridhar J; Zhang X; Zhao M; Foroozesh M
Chem Res Toxicol; 2014 Aug; 27(8):1431-9. PubMed ID: 25033111
[TBL] [Abstract][Full Text] [Related]
11. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 family 1 inhibitors and structure-activity relationships.
Liu J; Sridhar J; Foroozesh M
Molecules; 2013 Nov; 18(12):14470-95. PubMed ID: 24287985
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
[TBL] [Abstract][Full Text] [Related]
14. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
17. A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.
Liu J; Pham PT; Skripnikova EV; Zheng S; Lovings LJ; Wang Y; Goyal N; Bellow SM; Mensah LM; Chatters AJ; Bratton MR; Wiese TE; Zhao M; Wang G; Foroozesh M
J Med Chem; 2015 Aug; 58(16):6481-93. PubMed ID: 26222195
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo.
Thapliyal R; Maru GB
Food Chem Toxicol; 2001 Jun; 39(6):541-7. PubMed ID: 11346483
[TBL] [Abstract][Full Text] [Related]
19. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
Jerabek P; Martinek V; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
Dhawan A; Parmar D; Dayal M; Seth PK
Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]